Amaxa Nucleofector device

Friday, 28 May, 2010 | Supplied by: Capsugel Australia Pty Ltd

Amaxa Nucleofector device

Amaxa’s Nucleofector technology is a highly efficient non-viral method for transfection, based on two components: the Nucleofector device that delivers unique electrical parameters and Nucleofector kits that contain cell-type-specific Nucleofector solutions.

The electrical parameters of the Nucleofector are claimed to be different from other electroporation devices. Each electrical setting is displayed as a distinct program which has been adapted to the requirements of a particular cell type. Electrical parameters are preprogrammed into the Nucleofector, thus optimisation by the user is not necessary.

The device weighs 2.6 kg and is sized to fit under a sterile hood, suitable for sterile work with cells.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Cytek cFluor Human B Cell Monitoring Kit

The Cytek cFluor Human B Cell Monitoring Kit identifies B cell subsets in human peripheral blood...

Primerdesign exsig Mag RapidBead Pro Extraction Kit

Primerdesign's exsig Mag RapidBead Pro Extraction Kit is a next-generation, magnetic...

Cayman Chemical Cellular Metabolism Screening Library

Cayman Chemical's Cellular Metabolism Screening Library consists of two plates and contains...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd